Nigeria Lassa Fever Deaths Reach 109 as NCDC Reports Infection Slowdown

The Nigeria Centre for Disease Control (NCDC) has confirmed that the cumulative death toll from the ongoing Lassa fever outbreak has reached 109, a figure that highlights the severe impact of the virus despite a recorded decline in new infections. This statistical divergence—where mortality continues to climb while transmission appears to be slowing—suggests a critical phase in the public health response. For health officials and policy analysts, the data points to a lagging indicator effect, where deaths from cases contracted during the peak of the transmission season are only now being finalized in official records.

Lassa fever is endemic to Nigeria, with the Mastomys natalensis rodent serving as the primary reservoir for the virus. The current outbreak has followed a familiar seasonal pattern, typically peaking during the dry season when rodent populations move closer to human settlements. However, the 109 deaths recorded so far this year represent a significant burden on the national healthcare infrastructure. The NCDC’s latest epidemiological report indicates that while the number of suspected and confirmed cases has begun to trend downward, the case fatality rate (CFR) remains a point of intense concern for the Ministry of Health.

“

The Nigeria Centre for Disease Control (NCDC) has confirmed that the cumulative death toll from the ongoing Lassa fever outbreak has reached 109, a figure that highlights the severe impact of the virus despite a recorded decline in new infections.

The persistence of high mortality despite improved surveillance suggests that late presentation at healthcare facilities remains the single greatest hurdle to reducing the death toll. In many of the most affected states, including Ondo, Edo, and Bauchi, patients often seek medical attention only after the onset of severe symptoms, such as internal bleeding or organ failure. By this stage, the efficacy of the antiviral drug ribavirin is significantly diminished. Furthermore, the clinical similarity between early-stage Lassa fever and other common febrile illnesses like malaria often leads to diagnostic delays at the primary care level, where rapid testing for viral hemorrhagic fevers is frequently unavailable.

From a regulatory and health IT perspective, the NCDC has made strides in digitizing its surveillance through the SORMAS (Surveillance Outbreak Response Management and Analysis System) platform. This technology has allowed for more granular tracking of the outbreak, enabling the deployment of rapid response teams to specific local government areas. However, the data also reveals a need for enhanced laboratory capacity. While Nigeria has expanded its network of molecular laboratories capable of testing for Lassa fever, the turnaround time for results in remote areas can still impede immediate clinical decision-making.